Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy
Crossref DOI link: https://doi.org/10.1038/cgt.2016.22
Published Online: 2016-05-27
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hulin-Curtis, S L
Uusi-Kerttula, H
Jones, R
Hanna, L
Chester, J D
Parker, A L
Text and Data Mining valid from 2016-05-27
Article History
Received: 25 March 2016
Accepted: 20 April 2016
First Online: 27 May 2016
Competing interests
: The authors declare no conflict of interest.